Grifols | GRFS - PE Price to Earnings

Stock Price
7.97
Daily Change
-0.08 -0.99%
Monthly
-16.54%
Yearly
-1.60%
Q1 Forecast
7.59

Grifols reported 12.27 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cara Therapeutics 27.77 117.09 Sep/2021
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 11.15 0.29 Dec/2025
Grifols 12.27 4.84 Sep/2025
TherapeuticsMD 0.75 3.3 Mar/2023